GTS Securities’s Bionano Genomics BNGO Stock Holding History

GTS Securities’s Portfolio BNGO Stock Details BNGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-184	Closed	-$5.72K	–	4088
2024 Q2	$7.47K	Buy	+184	New	+$10.1K	﹤0.01%	3825

Other funds holding BNGO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

GTS Securities's BNGO Position: Q3 2024 in Review

GTS Securities sold out of Bionano Genomics (BNGO) in Q3 2024, closing a stake of 184 shares — an estimated $5.72K sold.

GTS Securities first reported a position in BNGO in Q2 2024 and held it in 1 quarter. The position peaked at $7.47K in Q2 2024. 47 funds tracked by Wall St. Rank hold BNGO as of Q3 2024.

GTS Securities reported no remaining Bionano Genomics position as of Q3 2024 after selling out during the quarter.
GTS Securities sold 184 Bionano Genomics shares in Q3 2024, an estimated $5.72K.
GTS Securities first reported a position in Bionano Genomics in Q2 2024 and held it in 1 quarter.
GTS Securities's Bionano Genomics position peaked at $7.47K in Q2 2024.
47 funds tracked by Wall St. Rank held Bionano Genomics as of Q3 2024.

Based on GTS Securities's 13F filing for Q3 2024, filed 13 Nov 2024.